| |
| |
|
| Insider
Information: |
Tessmer James F |
| Relationship: |
VP, Finance & Accounting |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
71,766 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$113,390 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
71,766 |
|
|
| Total
Value |
$113,390 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -33.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
VP, Finance & Accounting |
2021-03-15 |
71,766 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2021-03-15 |
4 |
S |
$6.90 |
$158,440 |
D/D |
(22,912) |
71,766 |
0 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2021-03-15 |
4 |
OE |
$3.31 |
$39,720 |
D/D |
12,000 |
83,766 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2021-02-28 |
4 |
D |
$7.19 |
$77,400 |
D/D |
(10,765) |
82,678 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,316 |
93,443 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,262 |
69,124 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2020-04-22 |
4 |
D |
$1.96 |
$7,834 |
D/D |
(3,997) |
65,127 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2020-02-28 |
4 |
D |
$2.77 |
$10,809 |
D/D |
(3,902) |
55,862 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,396 |
59,764 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2019-08-02 |
4 |
B |
$1.14 |
$11,400 |
D/D |
10,000 |
43,368 |
2.74 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,226 |
35,869 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2019-02-28 |
4 |
D |
$5.51 |
$13,781 |
D/D |
(2,501) |
33,368 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2018-06-08 |
4 |
S |
$12.91 |
$129,076 |
D/D |
(10,000) |
25,643 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2018-06-08 |
4 |
OE |
$10.15 |
$101,500 |
D/D |
10,000 |
35,643 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2018-02-28 |
4 |
D |
$8.53 |
$15,397 |
D/D |
(1,805) |
25,643 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,353 |
27,448 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2017-02-28 |
4 |
D |
$16.45 |
$45,896 |
D/D |
(2,790) |
20,095 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,939 |
22,885 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2016-06-06 |
4 |
AS |
$15.00 |
$22,500 |
D/D |
(1,500) |
15,946 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2016-06-06 |
4 |
OE |
$6.23 |
$9,345 |
D/D |
1,500 |
17,446 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2016-05-23 |
4 |
AS |
$13.00 |
$78,000 |
D/D |
(6,000) |
15,946 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2016-05-23 |
4 |
OE |
$6.23 |
$37,380 |
D/D |
6,000 |
21,946 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2016-02-29 |
4 |
D |
$9.07 |
$14,748 |
D/D |
(1,626) |
15,946 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2016-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,828 |
17,572 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2015-03-02 |
4 |
D |
$0.94 |
$8,499 |
D/D |
(9,041) |
82,225 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Finance & Accounting |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,625 |
91,266 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
